NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

For management of severe asthma with an eosinophilic phenotype, which class of medication is used?

Beta-2 adrenergic agonists
Corticosteroids
Interleukin receptor antagonists
Phosphodiesterase inhibitors

The correct answer is: Interleukin receptor antagonists

Interleukin receptor antagonists are the most effective class of medications for managing severe asthma with an eosinophilic phenotype. These medications specifically target the inflammatory response and the high levels of eosinophils in the airways, making them the most appropriate choice for this condition. Beta-2 adrenergic agonists may provide symptom relief, but they do not target the underlying cause of the asthma. Corticosteroids are effective for managing inflammation, but may not be enough for severe asthma with an eosinophilic phenotype. Phosphodiesterase inhibitors are used for treating other respiratory conditions, such as chronic obstructive pulmonary disease, and are not the first-line choice for asthma management.